Shorla Oncology

Recent Finacing

Series B

Recent Raise

$35M

Shorla Oncology is a pharmaceutical company that develops oncology drugs for orphan and pediatric cancers, with a focus on addressing drug shortages and improving the preparation and application of oncology medication.